Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
by Richard Daverman, PhD
July 17, 2013 -- Kunming Pharmaceutical, a TCM drug maker, will establish a joint venture in Uzbekistan with $3.5 million of initial capital. The other party to the JV is an Uzbek state-owned entity called the Uzfarmprom State Joint Stock Company. Kunming expects that building the plant will require a 250 million RMB ($41 million) investment. According to Kunming, domestic demand for its products is satisfied, forcing it to seek overseas opportunities. More details....
Stock Symbol: (SHA: 600422)
Help employers find you! Check out all the jobs and post your resume.
by Richard Daverman, PhD
July 17, 2013 -- Kunming Pharmaceutical, a TCM drug maker, will establish a joint venture in Uzbekistan with $3.5 million of initial capital. The other party to the JV is an Uzbek state-owned entity called the Uzfarmprom State Joint Stock Company. Kunming expects that building the plant will require a 250 million RMB ($41 million) investment. According to Kunming, domestic demand for its products is satisfied, forcing it to seek overseas opportunities. More details....
Stock Symbol: (SHA: 600422)
Help employers find you! Check out all the jobs and post your resume.
